Luke Evnin Insider Profile
4 Followers
Luke Evnin, Director at Werewolf Therapeutics, holds 0.00 shares in Werewolf Therapeutics (Ticker: HOWL), holds 2.49M shares in Oncorus (Ticker: ONCR), holds 4.52M shares in Harpoon Therapeutics (Ticker: HARP).
Luke Evnin's Trading History
| HOWLWerewolf Therapeutics | Jul 08, 2026 | Director | Uninformative Sell | 44.75K | $0.00 | |
| ONCROncorus | Oct 08, 2020 | ― | Uninformative Buy | ― | $314.10K | |
| HARPHarpoon Therapeutics | Feb 14, 2019 | ― | Uninformative Sell | 21.34K | $104.11M | |
| ~RDUSRadius Health | Sep 29, 2016 | ― | Uninformative Sell | ― | $58.78M | |
| EPZMEpizyme | Feb 11, 2014 | ― | Informative Sell | 13.65M | $3.55M | |
| ~RSLSReShape Lifesciences | Jan 09, 2014 | ― | Informative Sell | 1.39M | $7.12M | |
| HSTOQHistogen | Aug 01, 2013 | ― | Uninformative Buy | 183.88K | $13.11K | |
| PCRXPacira Pharmaceuticals | Jun 13, 2013 | Director | Uninformative Sell | 683.80K | $30.05M | |
| EPRSQEpirus Biopharma | Oct 28, 2011 | ― | Informative Sell | 760.97K | $5.57M | |
| ALTAltimmune | Nov 05, 2010 | Ten Percent Owner | Informative Buy | 7.67M | $10.44M | |
| PARDPoniard Pharmaceuticals | Nov 09, 2009 | Ten Percent Owner | Uninformative Sell | 4.05M | ― | |
| SOMXSomaxon Pharmaceuticals | ― | ― | ― | ― | ||
| HGENQHumanigen | ― | ― | ― | $28.96K | ||
| TMPMTurmeric Acquisition | ― | ― | ― | ― | ||
| SNDXSyndax Pharmaceuticals | ― | Director, Ten Percent Owner | ― | ― |
You May Also Like
Luke Evnin insider profile FAQ
What is the percentage of profitable transactions made by Luke Evnin?
The percentage of profitable transactions made by Luke Evnin is 60%.
What is the average return per transaction made by Luke Evnin?
The average return per transaction made by Luke Evnin is -2.40%.
What stocks does Luke Evnin hold?
Luke Evnin holds: HOWL, PARD, EPRSQ, SNDX, HARP, ONCR, TMPM, PCRX, EPZM, ALT, HGENQ, HSTOQ, ~RSLS, SOMX, ~RDUS stocks.
What was Luke Evnin’s latest transaction?
Luke Evnin’s latest transaction was an Uninformative Sell of $44.75K.
What was Luke Evnin's most profitable transaction?
Luke Evnin’s most profitable transaction was an Informative Sell of ~RSLS stock on January 9, 2014. The return on the trade was 52.30%.
What is Luke Evnin's role in Werewolf Therapeutics?
Luke Evnin's role in Werewolf Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
